Boston, MA · Founded 2020 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop novel neuropsychiatric medicines in areas of patient need. Seaport Therapeutics is based in Boston, MA and was founded in 2020. It is valued at about $740 million as of Oct 2026, set by institutional fund marks. It has raised $330 million across 1 recorded round; the latest was a $226 million later-stage round in Oct 2024.
PMV mark · valuation
$740.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$329.9M
Last round
Later Stage VC
Oct 2024
Team — not yet on record
No current team members for Seaport Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Seaport Therapeutics with a free account
·The complete investor list: 13 names
·Watch Seaport Therapeutics: the Monday email on marks, rounds and moves
